image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

Kape - Unikmind makes 285p cash offer

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KAPE
  • Price:
  • 294p
Unikmind, the investment vehicle of Israeli Teddy Sagi, has launched a £1.25bn takeover bid for Kape, which values the company at 285p a share. Unikmind already has 55% of the equity and has supported Kape’s buy-and-build deals in the past but sees Kape’s valuation as too low and now believes the most appropriate way to support this strategy is as a private business. The rather unsavory part of the offer is that Unikmind intends to requisition an EGM to delist the shares, regardless of the outcome; Sagi needs 75% of those voting at the EGM to delist and the market clearly feels the offer is too low with the shares over 285p. Vote against the offer. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe